Skip to main content

Advertisement

Log in

Prevalence of Prothrombotic Abnormalities in Patients with Acute Mesenteric Ischemia

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Acute mesenteric ischemia (AMI) is a rare condition that may be associated with a variety of congenital prothrombotic disorders (PDs). The purpose of this study was to assess the prevalence of these disorders in 28 AMI patients compared with 103 healthy individuals from the northeastern region of Turkey. They were screened for protein C, antithrombin III, and protein S deficiencies; and gene analysis was performed using the polymerase chain reaction. A PD was revealed in 16 (57%) patients and 33 (32%) controls (p = 0.020). Factor V Leiden (FVL), prothrombin G20210A mutation, and TT677 homozygous mutation of methylenetetrahydrofolate reductase was detected in 10 (36%) patients versus 16 (15%) controls (p = 0.035), 3 (11%) patients versus 10 (9%) controls (p = 1.00), and 1 (3%) patient versus no controls, respectively. Consistent with caucasian ethnic groups, there was high prevalence of PDs, especially FVL; and these abnormalities might be a significant predisposing factor in the pathogenesis of AMI.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Markis M, Rosendaal FR, Preston FE. Familial thrombophilia: genetic risk and management. J. Intern. Med. Suppl. 1997;740:9–15

    PubMed  Google Scholar 

  2. Margaglione M, D’Andrea G, d’Addedda M, et al. The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutation. Thromb. Haemost. 1998;79:907–911

    PubMed  Google Scholar 

  3. AğaoğLu N, Türkyılmaz S, Arslan MK. Prothrombotic disorders in patients with mesenteric vein thrombosis. J. Invest. Surg. 2003;16:299–304

    PubMed  Google Scholar 

  4. Gurgey A, Haznedaroğlu IC, Agesel T, et al. Two common genetic thrombotic risk factors: factor V Leiden and prothrombin G20210A in adult Turkisk patients with thrombosis. Am. J. Hematol. 2001;67:107–111

    Article  PubMed  Google Scholar 

  5. Akar N, Akar E, Dalgin G, et al. Frequency of factor V 1691 G-A mutation in Turkish population. Thromb. Haemost. 1997;78:1527–1529

    PubMed  Google Scholar 

  6. Akar N, Misirlioğlu M, Akar E, et al. Prothrombin gene 20210 G: a mutation in Turkish population. Am. J. Hematol. 1998;58:249

    Article  Google Scholar 

  7. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure of extracting DNA from human nucleated cells. Nucleic Acids Res 1998;16:1215

    Google Scholar 

  8. Rosendaal FR. Risk factors for venous thrombosis: prevalence, risk, and interaction. Semin. Hematol. 1997;34:171–187

    PubMed  Google Scholar 

  9. Shen MC, Lin JS, Tsay W. High prevalence of antithrombin III, protein C and protein S deficiency, but no factor V Leiden mutation in venous thrombophilic Chinese patients in Taiwan. Thromb.Res.1997;87:377–385

    Article  PubMed  Google Scholar 

  10. Lin JS, Shen NC, Tsay W. The mutation at position 20210 in the 3′-untranslated region of the prothrombin gone is extremely rare in Taiwanese Chinese patients with venous thrombophilia. Thromb. Haemost. 1998;80:343

    PubMed  Google Scholar 

  11. Rees DC, Cox M, Clegg JB. World distribution of FV Leiden. Lancet 1995;346:1133–1134

    Article  PubMed  Google Scholar 

  12. Ridker PM, Miletich JP, Hennekens CH, et al. Ethnic distribution of FV Leiden in 4047 men and women. J.A.M.A. 1997;277:1305–1130

    PubMed  Google Scholar 

  13. Cattaneo M, Chantatangkul V, Taioli E. The G20210: a mutation of the prothrombin gene in patients with previous first episodes of deep vein thrombosis: prevalence and association with factor V G1691A, methylenetetrahydrofolate reductase TT677 and plasma prothrombin levels. Thromb. Res. 1999;93:1–8

    Article  PubMed  Google Scholar 

  14. Gómez RR, Cuesta M, García M. Prevalence of the FV Leiden mutation in the Spanish population [abstract] Thromb. Haemost. 1997;77:224

    Google Scholar 

  15. Rosendaal FR, Doggen CJ, Zivelin A. Geographic distribution of the 20210 G to A prothrombin variant. Thromb. Haemost. 1998;79:706–708

    PubMed  Google Scholar 

  16. Souto JC, Coll I, Llobe D, et al. The prothrombin 20210A allele is the most prevalent genetic risk factor for venous thromboembolism in the Spanish population. Thromb. Haemost. 1998;80:306–309

    Google Scholar 

  17. Genoud V, Castrion M, Annichino-Bizzacchi J, et al. Prevalence of three prothrombotic polymorphisms factor V G1691A, factor II G20210A and methylenetetrahydrofolate reductase (MTHFR) C 677T in Argentina. Thromb. Res. 2000;100:127–131

    Article  PubMed  Google Scholar 

  18. Ma J, Stampfer MJ, Hennekens CH, et al. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in U.S. physicians. Circulation 1996;94:2410–2416

    PubMed  Google Scholar 

  19. Jacques PF, Bostom AG, William RR, et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996;3:7–9

    Google Scholar 

  20. Maurizio M, Giovanna DA, Marina DA, et al. The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the factor V Leiden and the prothrombin A20210 mutation. Thromb. Haemost. 1998;79:907–911

    PubMed  Google Scholar 

  21. Rintelen C, Pabinger I, Leckner K, et al. No evidence for an increase of the risk of venous thrombosis in patients with factor V Leiden by the homozygous mutation in the methylenetetrahydrofolate gene. Blood Coagul Fibrinolysis 1999;10: 101–105

    Google Scholar 

  22. Morita H, Taguchi J, Kurihara H, et al. Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease. Circulation 1997;95:2032–2036

    PubMed  Google Scholar 

  23. Motti C, Gnasso A, Bernardini S. Common mutation of methylenetetrahydrofolate reductase; correlation with homocysteine and other risk factors for vascular disease. Atherosclerosis 1998;139:377–383

    Article  PubMed  Google Scholar 

  24. Camacho Vanegas O, Giusti B, Restropo Fernandez CM, et al. Frequency of factor V (FV) Leiden and C677T methylenetetrahydrofolate reductase (MTHFR) mutations in Colombians. Thromb. Haemost. 1998;79:883–884

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nazım Ağaoğlu M.D..

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ağaoğlu, N., Türkyılmaz, S., Ovalı, E. et al. Prevalence of Prothrombotic Abnormalities in Patients with Acute Mesenteric Ischemia. World J. Surg. 29, 1135–1138 (2005). https://doi.org/10.1007/s00268-005-7692-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-005-7692-5

Keywords

Navigation